Multiple Sclerosis and Regulatory T Cells
- 573 Downloads
Multiple sclerosis (MS) is a complex genetic disease characterized by chronic inflammation of the central nervous system (CNS). The pathology of MS is largely attributed to autoreactive effector T cells that penetrate the blood–brain barrier and become activated within the CNS. As autoreactive T cells are present in the blood of both patients with MS and healthy individuals, other regulatory mechanisms exist to prevent autoreactive T cells from causing immune disorders. Active suppression by regulatory T (Treg) cells plays a key role in the control of self-antigen-reactive T cells and the induction of peripheral tolerance in vivo. In particular, the importance of antigen-specific Treg cells in conferring genetic resistance to organ-specific autoimmunity and in limiting autoimmune tissue damage has been documented in many disease models including MS.
We have found that the frequency of Tregs in MS patients is unchanged from controls, but their function measured in vitro may be diminished, correlating with impaired inhibitory activity in vivo. This review discusses the immunopathology of MS with particular focus given to regulatory T cells and their potential for the development of new therapies to treat this disease.
KeywordsRegulatory T cells immune system lymphocytes autoimmune disease multiple sclerosis
Work was supported by the NIH grants: UO1DK6192601, RO1NS2424710, PO1AI39671, and PO1NS38037; and grants from the National Multiple Sclerosis Society: RG2172C9 and RG3308A10, and from the 2004 FOCIS Centers of Excellence Amgen Award.
- 2.International Multiple Sclerosis Genetic ConsortiumHafler DA, Compston A, Sawcer S, Lander S, Daly MJ, DeJager PL, de Bakker PIW, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL. Novel risk alleles for multiple sclerosis identified by a whole genome association study. N Engl J Med 2007;357:851–62.PubMedCrossRefGoogle Scholar
- 34.Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. TIM-3 is expressed by cells of the innate immune system and promotes tissue inflammation. Science 2007;318(5853):1141–3.PubMedCrossRefGoogle Scholar
- 41.Ledeboer A, et al. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000;30(2):134–42.PubMedCrossRefGoogle Scholar
- 49.Sakaguchi S, et al. Organ-specific autoimmune-diseases induced in mice by elimination of T-cell subset 1. Evidence for the active participation of T-cells in natural self-tolerance—deficit of a T-cell subset as a possible cause of autoimmune-disease. J Exp Med 1985;161(1):72–87.PubMedCrossRefGoogle Scholar
- 68.Cao D, et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. J Immunol 1998;160:1532–8.Google Scholar